4 Notable Health Tech Funding Announcements in December

Editor’s Note: This roundup is intended to highlight some of the most notable funding rounds of the month and is not intended to be exhaustive.

Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds.

Curative Secures $150M Series B Funding

Curative, based in Austin, Texas, offers an employer-based health plan with $0 out-of-pocket costs, no co-pays, no deductibles and no coinsurance. Members only need to complete an annual preventive health visit to obtain the $0 refundable fee.

The Series B funding was led by Upside Vision Fund, TED President Chris Anderson, and included participation from Justin Mateen, founder of JAM Fund. Other investors include Mike Novogratz of Galaxy Digital, Duquesne Family Office of Stanley Druckenmiller, DCVC and Martin Varsavsky. The funding will help expand Curative’s operations nationally, according to the announcement.

Angle Health Raises $134 Million in Series B Funding

Angle Health, based in San Francisco, is a digital health benefits provider for employers. Its AI-powered app offers care navigation services through its care team. Its customizable health plans include telemedicine, behavioral health and other digital health solutions. The company can also assist with payment processing, billing and invoicing, and serves more than 3,000 employers in 44 states.

Angle Health’s Series B round was led by Portage and included participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC and Y Combinator. The round included a combination of debt and equity. In total, Angle Health has raised approximately $200 million.

Paradigm Health Raises $78 Million in Series B Funding

Paradigm Health offers an AI-powered platform that aims to provide equitable access to clinical trials for patients. The platform automates the matching of patients to clinical trials and helps health systems recruit eligible patients for trials.

The funding was led by ARCH Venture Partners, with participation from DFJ Growth, F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital and the American Cancer Society’s BrightEdge Fund. The funding “will be used to accelerate Paradigm Health’s expansion as demand increases from global biopharmaceutical companies for more efficient trials and health systems seeking to offer trials to patients closer to where they receive routine care,” according to the announcement.

Artera raises $65 million in funding

Artera, based in Santa Barbara, California, is a health technology company that leverages AI to help providers communicate more easily with patients. Its platform uses automated text, voice, and web messaging to manage things like scheduling, appointment scheduling, and billing.

Funding included support from Lead Edge Capital, Jackson Square Ventures, Health Velocity Capital, Heritage Medical Systems and Summation Health Ventures. This will help Artera further grow its business and adopt agentic AI in healthcare.

Photo: Abscent84, Getty Images